IP78-20: Who Truly Needs Adjuvant Therapy? A Simple Clinicopathologic Model Identifying Real Candidates for KEYNOTE-564–Defined Intermediate-High–Risk Clear Cell Renal Cell Carcinoma

IP78-20: Who Truly Needs Adjuvant Therapy? A Simple Clinicopathologic Model Identifying Real Candidates for KEYNOTE-564–Defined Intermediate-High–Risk Clear Cell Renal Cell Carcinoma

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)

147B

Abstract

Sessions

IP78: Kidney Cancer: Advanced (including drug therapy)

Monday, May 18, 2026 7:00 AM to 9:00 AM

Log in

See all the content and easy-to-use features by logging in or registering!